Building better workplace relationships and equipping people to manage conflict better.
\n \n\n \n \nAdverse drug reactions, commonly known as side effects, place a significant burden on health services and account for patient deaths, disease, and extra costs in the UK and worldwide.\r\n\r\nThis research is about the reporting of side effects of biologic medicines on patients.
\n \n\n \n \nOur research will use genetics to improve our understanding and treatment of musculoskeletal diseases, such as osteoarthritis and carpal tunnel syndrome, which cause more years of disability and pain than any other disease class.
\n \n\n \n \nFind out about our 2022-2024 alumni.
\n \n\n \n \nPHI has work that spans the worlds of climate change and health equity. Explore some of the themes of our work below, and find project pages, links and publications within them.
\n \n\n \n \nAmelia is a Science Communicator, and joined the PHI Lab in September 2023. She has a background in Biochemistry and research experience in science communication, and now leads on the various parts of PHI\u2019s outputs.
\n \n\n \n \nOne key feature of our research is using data collected from the world around us. This could be de-identified patient records, weather station measurements or satellite imagery. This real-world international evidence uses federated analytics to safely and securely combine individual person-level data into valuable learning.
\n \n\n \n \nArtificial Intelligence is one of the biggest areas of development and innovation today. In our research, we are applying AI technology to tackle one of the greatest challenges facing healthcare systems across the globe: the impact of the environment and climate change.
\n \n\n \n \n